Vimarsana
Biggest News Aggregation in the World

Page 4 - Jun Ma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jun Ma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jun Ma Today - Breaking & Trending Today

Devastating earthquake in Morocco claims more than 2,000 lives - Vimarsana News

Devastating earthquake in Morocco claims more than 2,000 lives

Chinese President Xi Jinping on Saturday extended the country's condolences to Moroccan King Mohammed VI over the devastating earthquake that shook the African country late on Friday night, which has caused more than 2,000 deaths as of press time.

lyster-health-clinic-celebration - Vimarsana News

lyster-health-clinic-celebration

Celebration of the man called the “Father of Army Aviation Medicine” started Monday at the Lyster Health Clinic on Fort Novosel and culminated with a birthday celebration Friday from 11

Patients With High BMI Fare Better in Head and Neck Cancer - Vimarsana News

Patients With High BMI Fare Better in Head and Neck Cancer

Patients with head and neck cancer and obesity saw better treatment response and survival after chemoradiation, compared with patients with the same type of cancer but a normal weight.

Sintilimab Plus Chemoradiotherapy Improves EFS in Locally Advanced Nasopharyngeal Carcinoma - Vimarsana News

Sintilimab Plus Chemoradiotherapy Improves EFS in Locally Advanced Nasopharyngeal Carcinoma

The addition of sintilimab to chemoradiotherapy demonstrated a significant reduction in the risk of disease recurrence or death, distant metastasis and locoregional recurrence compared with chemoradiotherapy alone as frontline therapy in patients with locally advanced nasopharyngeal carcinoma, according to findings from the phase 3 CONTINUUM trial.

Dr Ma on Sintilimab Plus Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma - Vimarsana News

Dr Ma on Sintilimab Plus Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Jun Ma, MD, discusses findings from the phase 3 CONTINUUM trial of sintilimab in combination with induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.